2-Amino-4-methoxyindole-3-carboxamide | 1204578-81-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 2-Amino-4-methoxyindole-3-carboxamide
• 英文别名: 2-amino-4-methoxy-1H-indole-3-carboxamide
• CAS: 1204578-81-3
• 化学式: C₁₀H₁₁N₃O₂
• 分子量: 205.216
• InChiKey: NCDCTZWKIMFSRB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.1
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  94.1
• 氢给体数：
  3
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  3-硝基苯甲醚 在 palladium 10% on activated carbon 一水合肼 、 三乙胺 作用下， 以 四氢呋喃 、 乙醇 、 氯仿 为溶剂， 反应 14.0h， 生成 2-Amino-4-methoxyindole-3-carboxamide 、 2-amino-6-methoxyindole-3-carboxamide
  参考文献：
  名称：

  NOVEL INDOLE DERIVATIVE HAVING CARBAMOYL GROUP, UREIDO GROUP AND SUBSTITUTED OXY GROUP

  摘要：

  公开号：

  EP2314575B1

文献信息

• NOVEL INDOLE DERIVATIVE HAVING, CARBAMOYL GROUP, UREIDO GROUP AND SUBSTITUTED OXY GROUP
  申请人：Kawashima Kenji

  公开号：US20110124668A1

  公开（公告）日：2011-05-26

  The present invention relates to synthetic studies on novel indole derivatives having a carbamoyl group, a ureido group and a substituted oxy group or a salt thereof, and pharmaceutical actions of the derivatives. The compound and a salt thereof represented by the general formula (1) has an IKKβ inhibitory activity and is useful as a preventive and/or therapeutic agent for diseases considered to be associated with IKKβ. In the formula, R 1 represents a hydrogen atom, a lower alkyl group which may have a substituent, a hydroxy group, or a lower alkoxy group which may have a substituent, or the like; R 2 represents a hydrogen atom, a lower alkyl group which may have a substituent, a lower cycloalkyl group which may have a substituent, an aryl group which may have a substituent, or a heterocyclic group which may have a substituent, or the like; R 3 represents a halogen atom, a lower alkyl group which may have a substituent, a lower alkenyl group which may have a substituent, a lower alkynyl group which may have a substituent, a lower cycloalkyl group which may have a substituent, an aryl group which may have a substituent, a heterocyclic group which may have a substituent, or the like; m represents 0, 1, 2, or the like.

  本发明涉及具有氨基甲酰基、尿素基和取代氧基或其盐的新型吲哚衍生物的合成研究以及其药理作用。通式（1）表示的化合物及其盐具有IKKβ抑制活性，并可用作预防和/或治疗与IKKβ相关的疾病的药物。在该式中，R1表示氢原子、可能具有取代基的较低烷基、羟基或可能具有取代基的较低烷氧基等；R2表示氢原子、可能具有取代基的较低烷基、可能具有取代基的较低环烷基、可能具有取代基的芳基或可能具有取代基的杂环基等；R3表示卤素原子、可能具有取代基的较低烷基、可能具有取代基的较低烯基、可能具有取代基的较低炔基、可能具有取代基的较低环烷基、可能具有取代基的芳基、可能具有取代基的杂环基等；m表示0、1、2或类似物。
• NOVEL INDOLE DERIVATIVE HAVING CARBAMOYL GROUP, UREIDE GROUP AND SUBSTITUTED OXY GROUP
  申请人：Santen Pharmaceutical Co., Ltd

  公开号：EP2314575A1

  公开（公告）日：2011-04-27

  The present invention relates to synthetic studies on novel indole derivatives having a carbamoyl group, a ureido group and a substituted oxy group or a salt thereof, and pharmaceutical actions of the derivatives. The compound and a salt thereof represented by the general formula (1) has an IRKβ inhibitory activity and is useful as a preventive and/or therapeutic agent for diseases considered to be associated with IKKβ. In the formula, R1 represents a hydrogen atom, a lower alkyl group which may have a substituent, a hydroxy group, or a lower alkoxy group which may have a substituent, or the like; R2 represents a hydrogen atom, a lower alkyl group which may have a substituent, a lower cycloalkyl group which may have a substituent, an aryl group which may have a substituent, or a heterocyclic group which may have a substituent, or the like; R3 represents a halogen atom, a lower alkyl group which may have a substituent, a lower alkenyl group which may have a substituent, a lower alkynyl group which may have a substituent, a lower cycloalkyl group which may have a substituent, an aryl group which may have a substituent, a heterocyclic group which may have a substituent, or the like; m represents 0, 1, 2, or the like.

  本发明涉及具有氨基甲酰基、脲基和取代氧基的新型吲哚衍生物或其盐的合成研究，以及这些衍生物的药物作用。通式（1）代表的化合物及其盐具有 IRKβ 抑制活性，可作为预防和/或治疗被认为与 IKKβ 有关的疾病的药物。式中，R1 代表氢原子、可能具有取代基的低级烷基、羟基或可能具有取代基的低级烷氧基等；R2 代表氢原子、可能具有取代基的低级烷基、可能具有取代基的低级环烷基、可能具有取代基的芳基或可能具有取代基的杂环基等；R3 代表卤素原子、可具有取代基的低级烷基、可具有取代基的低级烯基、可具有取代基的低级炔基、可具有取代基的低级环烷基、可具有取代基的芳基、可具有取代基的杂环基等；m 代表 0、1、2 或类似物。
• US8445529B2
  申请人：——

  公开号：US8445529B2

  公开（公告）日：2013-05-21
• NOVEL INDOLE DERIVATIVE HAVING CARBAMOYL GROUP, UREIDO GROUP AND SUBSTITUTED OXY GROUP
  申请人：Santen Pharmaceutical Co., Ltd

  公开号：EP2314575B1

  公开（公告）日：2013-06-19